{
  "id": 9387113,
  "title": "This test screens for 50 cancers — but whether Medicare and other health insurers will cover it hinges on FDA approval",
  "url": "https://urgent.news/2026/09/23/this-test-screens-for-50-cancers-but-whether-medicare-and-other",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-23T18:15:00.000Z",
  "source": {
    "name": "MarketWatch",
    "slug": "marketwatch",
    "url": "https://www.marketwatch.com/story/fda-advisers-are-reviewing-a-multicancer-detection-test-medicare-coverage-could-follow-77cb8817?mod=mw_rss_topstories"
  },
  "original_language": "en",
  "account": null,
  "summary": "Grail’s Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect later-stage cancers.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 4,
    "also_reported_by": [
      {
        "outlet": "Winnipeg Free Press",
        "title": "Grail’s cancer blood test faces high-stakes FDA review",
        "url": "https://urgent.news/2026/09/23/grails-cancer-blood-test-faces-high-stakes-fda-review",
        "published": "2026-09-23T13:23:13.000Z"
      },
      {
        "outlet": "Quartz",
        "title": "FDA advisers are voting on Grail's multicancer blood test as Medicare coverage hangs in the balance",
        "url": "https://urgent.news/2026/09/23/fda-advisers-are-voting-on-grails-multicancer-blood-test-as-medicare",
        "published": "2026-09-23T13:30:33.000Z"
      },
      {
        "outlet": "Medical Xpress",
        "title": "Grail's cancer blood test faces high-stakes FDA review",
        "url": "https://urgent.news/2026/09/23/grails-cancer-blood-test-faces-high-stakes-fda-review-9395655",
        "published": "2026-09-23T18:40:09.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}